Regeneron's Covid Therapy Propels Strong Second-Quarter Growth bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Dr. George Yancopoulos, the Mind Behind Regeneron’s Covid Treatment
” width=”684″>Dr. George Yancopooulos and Dr. Leonard Schleifer of Regeneron at company headquarters in New York. Credit: Regeneron/Facebook
Dr. George Yancopoulos is the CEO of Regeneron, maker of one of two experimental therapies for the treatment of “mild to moderate” cases of Covid-19 that was authorized by the US’ Food and Drug Administration.
George Yancopoulos is the founding scientist and Chief Scientific Officer of Regeneron Pharmaceuticals, working alongside Founder and Chief Executive Officer Leonard Schleifer, M.D. In 2016, Yancopoulos was also named President of Regeneron.
George Yancopoulos and Regeneron
Dr. Albert Bourla, Dr. Ugur Sahin and Dr. George Yancopoulos will be grated the Bishop Athenagoras Human Rights Award in October for their development of coronavirus vaccines and treatment,ents. Credit: Order of St. Andrew, Archons of the Ecumenical Patriarchate in AmericaGreek scientists Dr. Albert Bourla and Dr. George Yancopoulos, along with Dr. Ugur Sahin —…